NUVB Kelas A Nuvation Bio Inc. Class A Common Stock
NYSE · Pharmaceuticals · Lihat di SEC EDGAR ↗ 10-K/10-Q Agu 6, 2026
$4,57
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$3,92rendah 52m
$9,75tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.58B
P/E (TTM)
-10.4
EPS (TTM)
$-0.44
Pendapatan (TTM)
$170M
lencana Anda
Rentang 52M
$4–$10
Peringkat Analis
BUY
Target Harga
$13
P/E
-10.4
ROE
-47.8%
Margin Laba Bersih
-88.2%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
NUVB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.57
Kapitalisasi Pasar (MRQ)
$1.58B
P/E (TTM)
-10.4
EPS (TTM)
$-0.44
Pendapatan (TTM)
$170M
ROE (TTM)
-47.8%
D/E Utang/Ekuitas (MRQ)
0.0
Rentang 52M
$4–$10
NUVB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$63M2023-12-31 → 2025-12-31
EPS$-0.602021-12-31 → 2025-12-31
Margin bersih-88.2%2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | NUVB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -10.4rata-rata 5T ≈-8.8 | ≈-8.8 | · | · | |
| P/S (TTM) | 9.3 | · | 11.6 | Nilai wajar | |
| P/B (MRQ) | 6.2rata-rata 5T ≈3.7 | ≈3.7 | 4.1 | Terlalu mahal | |
| EV / EBITDA | -5.0 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -9.1rata-rata 5T ≈-14.0 | ≈-14.0 | · | · | |
| EV / Pendapatan (TTM) | 5.5 | · | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 6.5rata-rata 5T ≈3.2 | ≈3.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | NUVB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -81.0% | · | -62.9% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -338.7% | · | -29.4% | Lemah | |
| Margin Sebelum Pajak (TTM) | -88.2% | · | -18.0% | Lemah | |
| Margin Laba Bersih (TTM) | -88.2% | · | -59.2% | Lemah | |
| ROA (TTM) | -21.5%rata-rata 5T ≈-41.4% | ≈-41.4% | -10.3% | Lemah | |
| ROE (TTM) | -47.8%rata-rata 5T ≈-51.3% | ≈-51.3% | -12.6% | Lemah | |
| ROIC | -68.4%rata-rata 5T ≈-56.3% | ≈-56.3% | -14.8% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | NUVB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.0 | · | 0.4 | Utang rendah | |
| Rasio Lancar (MRQ) | 8.4rata-rata 5T ≈28.1 | ≈28.1 | 10.7 | Di bawah rata-rata | |
| Quick Ratio (Rasio Cepat) | 6.4rata-rata 5T ≈27.6 | ≈27.6 | 9.9 | Di bawah rata-rata |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | NUVB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 699.0% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | NUVB | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.1 | · | 0.3 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$206.2K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.7%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $-0.15 | $-0.19 | 20.6% |
| 31 Maret 2026 | Mei 19, 2026 | $0.01 | $0.01 | — |
| 31 Des. 2025 | $-0.11 | $-0.09 | -20.7% | |
| 30 Sep. 2025 | $-0.16 | $-0.17 | 7.0% | |
| 30 Juni 2025 | $-0.17 | $-0.17 | 0.87% | |
| 31 Maret 2025 | $-0.16 | $-0.16 | 0.93% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $63M | $8M | $0 | |
| Cost of Revenue | · | $7M | $0 | |
| Gross Profit | · | $795.0K | $0 | |
| R&D Expense | $115M | $99M | $71M | |
| SG&A Expense | $152M | $69M | $29M | |
| Operating Expenses | $276M | $600M | $100M | |
| Operating Income | $-213M | $-593M | $-100M | |
| Other Non-op | $2M | $-109.0K | $24M | |
| Pretax Income | $-205M | $-568M | $-76M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-205M | $-568M | $-76M | |
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | |
| EPS (Diluted) | $-0.60 | $-2.11 | $-0.35 | |
| Shares (Basic) | 341,541 | 268,772 | 218,880 | |
| Shares (Diluted) | 341,541 | 268,772 | 218,880 | |
| EBITDA | $-213M | $-593M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $164M | $36M | $43M | |
| Short-term Investments | $365M | $467M | $569M | |
| Inventory | $11M | $0 | · | |
| Prepaid Expense | $12M | $7M | $2M | |
| Current Assets | $572M | $526M | $616M | |
| PP&E (Net) | $564.0K | $586.0K | $717.0K | |
| PP&E (Gross) | $2M | $1M | $1M | |
| Accum. Depreciation | $1M | $874.0K | $666.0K | |
| Intangibles | $11M | $5M | $0 | |
| Other Non-current Assets | $8M | $7M | $587.0K | |
| Total Assets | $595M | $541M | $621M | |
| Accounts Payable | $9M | $6M | $2M | |
| Accrued Liabilities | $45M | $33M | $10M | |
| Short-term Debt | $6M | $6M | $0 | |
| Current Liabilities | $82M | $58M | $14M | |
| Capital Leases | $3M | $969.0K | $2M | |
| Total Liabilities | $289M | $77M | $16M | |
| Long-term Debt | $47M | · | · | |
| Total Debt | $6M | $6M | · | |
| Common Stock | $1.42B | $1.37B | $948M | |
| Retained Earnings | $-1.12B | $-911M | $-343M | |
| AOCI | $-187.0K | $573.0K | $181.0K | |
| Stockholders' Equity | $306M | $464M | $605M | |
| Liabilities + Equity | $595M | $541M | $621M | |
| Shares Outstanding | 346,503,675 | 337,837,872 | 219,046,219 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $683.0K | $222.0K | |
| Stock-based Comp | $36M | $32M | $20M | |
| Operating Cash Flow | $-173M | $-130M | $-68M | |
| Investing Cash Flow | $100M | $123M | $9M | |
| Financing Cash Flow | $203M | $331.0K | $628.0K | |
| Net Change in Cash | $128M | $-7M | $-58M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | · | 10.1% | · | |
| Operating Margin | -338.7% | -7527.3% | · | |
| Net Margin | -325.3% | -7213.8% | · | |
| Pretax Margin | -325.3% | -7213.8% | · | |
| EBITDA Margin | -338.7% | -7527.3% | · | |
| ROA | -36.0% | -97.7% | · | |
| ROE | -60.3% | -117.5% | · | |
| ROIC | -68.4% | -126.1% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.0 | 9.0 | · | |
| Quick Ratio | 6.4 | 8.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.90 | $1.37 | · | |
| Revenue / Share | $184.17 | $29.29 | · | |
| Cash Flow / Share | $-507.78 | $-485.22 | · | |
| Cash / Share | $0.49 | $0.11 | · | |
| EPS (TTM) | $-0.60 | $-2.11 | $-0.35 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 699.0% | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $63M | $8M | $0 | |
| Net Income TTM | $-205M | $-568M | $-76M | |
| Market Cap | $3.03B | $899M | · | |
| Enterprise Value | $2.50B | $402M | · | |
| P/E | -14.9 | -1.3 | -4.3 | |
| P/S | 48.1 | 114.1 | · | |
| P/B | 9.9 | 1.9 | · | |
| P / Tangible Book | 10.3 | 2.0 | 0.5 | |
| P / Cash Flow | -17.5 | -6.9 | · | |
| EV / EBITDA | -11.8 | -0.7 | · | |
| EV / Revenue | 39.8 | 51.1 | · | |
| Earnings Yield | -6.7% | -79.3% | -23.2% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $83M | $42M | $13M | $5M | $3M | $6M | $727.0K | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | $3M | $3M | $2M | · | $2M | $1M | $0 | · | · | · | |
| Gross Profit | · | · | · | $10M | $2M | $990.0K | · | $-788.0K | $88.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $31M | $35M | $34M | $29M | $27M | $25M | $29M | $28M | $29M | $13M | $15M | $19M | $19M | |
| SG&A Expense | $43M | $38M | $40M | $37M | $38M | $35M | $26M | $20M | $16M | $7M | $5M | $8M | $8M | |
| Operating Expenses | $83M | $79M | $84M | $66M | $68M | $62M | $63M | $47M | $470M | $20M | $21M | $26M | $26M | |
| Operating Income | $-51M | $4M | $-34M | $-56M | $-64M | $-59M | $-54M | $-48M | $-470M | $-20M | $-21M | $-26M | $-26M | |
| Interest Expense | · | · | · | $5M | · | · | · | · | $132.0K | · | · | · | $0 | |
| Other Non-op | $-12M | $2M | $-9M | $642.0K | $5M | $6M | $-20M | $7M | $8M | $5M | $7M | $7M | $5M | |
| Pretax Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| EPS (Basic) | $-0.18 | $0.02 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| EPS (Diluted) | $-0.18 | $0.01 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| Shares (Basic) | 348,770 | 347,332 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| Shares (Diluted) | 348,770 | 377,521 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| EBITDA | $-51M | $4M | · | $-56M | $-64M | $-59M | · | $-48M | $-470M | $-20M | · | $-26M | $-26M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259M | $125M | $164M | $99M | $248M | $48M | $36M | $30M | $34M | $35M | $43M | $24M | $50M | |
| Short-term Investments | $402M | $408M | $365M | $450M | $360M | $414M | $467M | $519M | $543M | $562M | $569M | $595M | $581M | |
| Inventory | $20M | $16M | $11M | $6M | $552.0K | $14.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $14M | $16M | $12M | $9M | $8M | $8M | $7M | $12M | $6M | $7M | $2M | $3M | $4M | |
| Current Assets | $726M | $592M | $572M | $578M | $623M | $476M | $526M | $565M | $587M | $608M | $616M | $625M | $637M | |
| PP&E (Net) | $715.0K | $535.0K | $564.0K | $560.0K | $615.0K | $562.0K | $586.0K | $719.0K | $751.0K | $686.0K | $717.0K | $764.0K | $804.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $971.0K | $874.0K | $839.0K | $782.0K | · | $666.0K | · | · | |
| Intangibles | $10M | $11M | $11M | $12M | $12M | $4M | $5M | $3M | $3M | · | $0 | · | · | |
| Other Non-current Assets | $4M | $4M | $8M | $7M | $7M | $7M | $7M | $480.0K | $1M | $1M | $587.0K | $587.0K | · | |
| Total Assets | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Accounts Payable | $12M | $22M | $9M | $15M | $22M | $11M | $6M | $12M | $5M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $45M | $33M | $45M | $33M | $24M | $24M | $33M | $24M | $20M | $11M | $10M | $12M | $10M | |
| Short-term Debt | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $8M | $12M | · | $0 | · | · | |
| Current Liabilities | $87M | $80M | $82M | $68M | $66M | $53M | $58M | $59M | $51M | $16M | $14M | $16M | $13M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $4M | $969.0K | $985.0K | $972.0K | $2M | $2M | $3M | $2M | |
| Total Liabilities | $491M | $291M | $289M | $276M | $274M | $73M | $77M | $69M | $63M | $19M | $16M | $19M | $17M | |
| Long-term Debt | $243M | $47M | $47M | $47M | $47M | · | · | · | · | · | · | · | · | |
| Total Debt | $6M | $6M | · | $6M | $6M | $6M | · | $8M | $12M | · | · | · | · | |
| Common Stock | $1.43B | $1.43B | $1.42B | $1.40B | $1.40B | $1.38B | $1.37B | $1.36B | $1.08B | $953M | $948M | $944M | $938M | |
| Retained Earnings | $-1.17B | $-1.11B | $-1.12B | $-1.08B | $-1.02B | $-964M | $-911M | $-861M | $-820M | $-358M | $-343M | $-329M | $-309M | |
| AOCI | $-3M | $-2M | $-187.0K | $-139.0K | $-327.0K | $545.0K | $573.0K | $1M | $-1M | $-1M | $181.0K | $-3M | $-4M | |
| Stockholders' Equity | $254M | $320M | $306M | $326M | $373M | $419M | $464M | $503M | $257M | $594M | $605M | $612M | $625M | |
| Liabilities + Equity | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Shares Outstanding | 346,503,675 | 346,503,675 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 336,248,642 | 248,624,729 | 219,083,219 | 219,046,219 | 218,944,053 | 218,899,462 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $536.0K | $536.0K | $539.0K | $534.0K | $356.0K | $310.0K | $219.0K | $162.0K | $244.0K | $58.0K | $55.0K | $55.0K | $56.0K | |
| Stock-based Comp | $10M | $9M | $8M | $8M | $12M | $8M | $10M | $7M | $10M | $5M | $4M | $5M | $6M | |
| Operating Cash Flow | $-43M | $5M | $-30M | $-53M | $-48M | $-43M | $-46M | $-31M | $-37M | $-16M | $-15M | $-16M | $-17M | |
| Investing Cash Flow | $6M | $-44M | $87M | $-97M | $55M | $54M | $52M | $29M | $34M | $8M | $33M | $-10M | $37M | |
| Financing Cash Flow | $171M | $44.0K | $8M | $501.0K | $193M | $548.0K | $-900.0K | $-2M | $3M | $21.0K | $120.0K | $77.0K | $133.0K | |
| Net Change in Cash | $133M | $-39M | $65M | $-149M | $200M | $12M | $6M | $-4M | $-225.0K | $-8M | $18M | $-26M | $20M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 74.5% | 46.7% | 32.1% | · | -108.4% | 6.1% | · | · | · | · | |
| Operating Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| Net Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| Pretax Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| EBITDA Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| ROA | -9.0% | 0.98% | · | -9.5% | -9.5% | -9.6% | · | -6.9% | -74.8% | -2.3% | · | -3.0% | -3.0% | |
| ROE | -20.1% | 1.5% | · | -13.5% | -18.7% | -10.5% | · | -7.4% | -104.9% | -2.4% | · | -3.1% | -3.1% | |
| ROIC | -19.7% | 1.2% | · | -17.0% | -16.8% | -13.9% | · | -9.4% | -175.0% | -3.4% | · | -4.3% | -4.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 7.4 | · | 8.5 | 9.4 | 9.0 | · | 9.6 | 11.5 | 38.6 | · | 38.7 | 47.5 | |
| Quick Ratio | 7.6 | 6.7 | · | 8.1 | 9.2 | 8.7 | · | 9.3 | 11.3 | 37.9 | · | 38.4 | 47.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | -11.0 | · | · | · | · | -3563.5 | · | · | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | · | · | · | 1.2 | 9.3 | 299.1 | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.73 | $0.92 | · | $0.96 | $1.10 | $1.24 | · | $1.50 | $1.03 | $2.71 | · | $2.79 | $2.85 | |
| Revenue / Share | $90.85 | $220.46 | · | $38.32 | $14.18 | $9.11 | · | $2.66 | $5.86 | · | · | · | · | |
| Cash Flow / Share | · | $13.43 | · | · | · | $-125.89 | · | · | · | $-71.68 | · | · | · | |
| Cash / Share | $0.75 | $0.36 | · | $0.29 | $0.73 | $0.14 | · | $0.09 | $0.14 | $0.16 | · | $0.11 | $0.23 | |
| EPS (TTM) | $-0.44 | $-0.43 | · | $-0.49 | $-0.48 | $-2.20 | · | $-2.18 | $-2.12 | $-0.32 | · | $-0.38 | $-0.41 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $143M | · | $27M | $14M | $11M | · | $2M | $1M | $0 | · | · | · | |
| Net Income TTM | $-150M | $-146M | · | $-217M | $-203M | $-606M | · | $-532M | $-511M | $-69M | · | $-83M | $-90M | |
| Market Cap | $1.97B | $1.49B | · | $1.25B | $659M | $595M | · | $770M | $726M | $797M | · | $293M | $394M | |
| Enterprise Value | $1.31B | $959M | · | $707M | $57M | $139M | · | $229M | $160M | · | · | · | · | |
| P/E | -12.9 | -10.0 | · | -7.6 | -4.1 | -0.8 | · | -1.1 | -1.4 | -11.4 | · | -3.5 | -4.4 | |
| P/S | 11.6 | 10.4 | · | 46.7 | 45.9 | 54.3 | · | 356.2 | 505.9 | · | · | · | · | |
| P/B | 7.8 | 4.7 | · | 3.8 | 1.8 | 1.4 | · | 1.5 | 2.8 | 1.3 | · | 0.5 | 0.6 | |
| P / Tangible Book | 8.1 | 4.8 | · | 4.0 | 1.8 | 1.4 | · | 1.5 | 2.9 | 1.3 | · | 0.5 | 0.6 | |
| P / Cash Flow | · | 293.3 | · | · | · | -13.9 | · | · | · | -50.8 | · | · | · | |
| EV / Revenue | 7.7 | 6.7 | · | 26.4 | 3.9 | 12.6 | · | 106.1 | 111.8 | · | · | · | · | |
| Earnings Yield | -7.8% | -10.0% | · | -13.2% | -24.6% | -125.0% | · | -95.2% | -72.6% | -8.8% | · | -28.4% | -22.8% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $63M | $8M | $0 | · | · |
| Margin Kotor % | · | 10.1% | · | · | · |
| Margin Operasi % | -338.7% | -7527.3% | · | · | · |
| Laba Bersih | $-205M | $-568M | $-76M | $-104M | $-87M |
| EPS Dilusian | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.0 | 0.0 | · | · | · |
| Rasio Lancar | 7.0 | 9.0 | · | 50.7 | 45.6 |
| Rasio Cepat | 6.4 | 8.6 | · | 50.2 | 45.2 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 257 pengaju · $1.5B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
257
Nilai yang dipegang
$1.5B
Posisi baru
39
Posisi yang keluar
25
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 39 (-9 vs Kuartal sebelumnya) | 25 (-8 vs Kuartal sebelumnya) | 108 (+20 vs Kuartal sebelumnya) | 55 (-6 vs Kuartal sebelumnya) | +17.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $296.668.075 | 52.230.295 | 20,30% | Saham |
| BlackRock, Inc. | $156.943.154 | 27.630.837 | 10,74% | Saham |
| Decheng Capital LLC | $147.421.214 | 25.954.439 | 10,09% | Saham |
| VANGUARD GROUP INC | $139.378.229 | 15.555.606 | 9,54% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.702.840 | 11.919.514 | 4,63% | Saham |
| Omega Fund Management, LLC | $45.900.586 | 8.081.089 | 3,14% | Saham |
| Laurion Capital Management LP | $44.417.674 | 7.820.013 | 3,04% | Saham |
| STATE STREET CORP | $41.866.110 | 7.370.794 | 2,86% | Saham |
| UBS Group AG | $36.208.324 | 6.374.705 | 2,48% | Opsi beli |
| GEODE CAPITAL MANAGEMENT, LLC | $35.477.953 | 6.244.805 | 2,43% | Saham |
| AMERICAN CENTURY COMPANIES INC | $25.557.979 | 4.499.643 | 1,75% | Saham |
| BANK OF AMERICA CORP /DE/ | $20.048.969 | 3.529.748 | 1,37% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $18.741.484 | 3.299.557 | 1,28% | Saham |
| Redmile Group, LLC | $17.216.131 | 3.031.009 | 1,18% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15.271.623 | 2.688.666 | 1,05% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $13.384.517 | 2.356.429 | 0,92% | Saham |
| NORTHERN TRUST CORP | $13.188.238 | 2.321.873 | 0,90% | Saham |
| ALGERT GLOBAL LLC | $12.935.393 | 2.277.358 | 0,89% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.694.382 | 2.058.870 | 0,80% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $11.631.936 | 2.047.876 | 0,80% | Saham |
| ARMISTICE CAPITAL, LLC | $11.360.000 | 2.000.000 | 0,78% | Saham |
| CITADEL ADVISORS LLC | $11.293.715 | 1.988.330 | 0,77% | Saham |
| GOLDMAN SACHS GROUP INC | $10.818.616 | 1.904.686 | 0,74% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $10.090.827 | 1.776.554 | 0,69% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $9.978.738 | 1.756.820 | 0,68% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9.211.176 | 1.621.686 | 0,63% | Saham |
| Knoll Capital Management, LLC | $9.079.996 | 1.598.591 | 0,62% | Saham |
| MORGAN STANLEY | $8.277.652 | 1.457.333 | 0,57% | Saham |
| Jump Financial, LLC | $7.715.774 | 1.358.411 | 0,53% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $7.645.252 | 1.345.995 | 0,52% | Saham |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $7.531.278 | 1.344.871 | 0,52% | Saham |
| FIRST TRUST ADVISORS LP | $7.397.274 | 1.302.337 | 0,51% | Saham |
| ABRAMS CAPITAL MANAGEMENT, L.P. | $7.216.463 | 1.270.504 | 0,49% | Saham |
| TWO SIGMA INVESTMENTS, LP | $7.090.963 | 1.248.409 | 0,49% | Saham |
| NewEdge Advisors, LLC | $6.996.243 | 1.231.733 | 0,48% | Saham |
| D. E. Shaw & Co., Inc. | $6.475.200 | 1.140.000 | 0,44% | Saham |
| UBS Group AG | $6.343.884 | 1.116.881 | 0,43% | Saham |
| Nuveen, LLC | $6.155.007 | 1.083.628 | 0,42% | Saham |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.802.268 | 1.021.526 | 0,40% | Saham |
| Woodline Partners LP | $5.541.022 | 975.532 | 0,38% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.195.945 | 914.779 | 0,36% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $4.065.637 | 715.781 | 0,28% | Saham |
| Bank of New York Mellon Corp | $3.803.823 | 669.687 | 0,26% | Saham |
| Beacon Pointe Advisors, LLC | $3.591.186 | 632.251 | 0,25% | Saham |
| TWO SIGMA ADVISERS, LP | $3.522.176 | 393.100 | 0,24% | Saham |
| Invesco Ltd. | $3.336.387 | 587.392 | 0,23% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.037.431 | 534.759 | 0,21% | Saham |
| ACT CAPITAL MANAGEMENT, LLC | $2.953.600 | 520.000 | 0,20% | Saham |
| JPMORGAN CHASE & CO | $2.893.055 | 515.696 | 0,20% | Saham |
| Swiss National Bank | $2.765.024 | 486.800 | 0,19% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Claudio Nessi, Otello Stampacchia ×3 pengajuan | 18 Okt. 2024 | · | Pengajuan awal | · | SEC |
| Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Decheng Anbio Limited, Xiangmin Cui | 10 Sep. 2024 | · | Pengajuan awal | Kampanye dewan | SEC |
| David Hung, M.D. ×2 pengajuan | 26 Maret 2024 | · | Pengajuan awal | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 12 pejabat · 11 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | 11 Nov. 2024 S | 3.866.228 | 0 | 0 | $0 |
| Philippe Sauvage | Chief Financial Officer | 15 Juli 2026 M | 54.131 | 0 | 1 | $-286.485 |
| Jennifer A. Fox | Chief Financial Officer | 28 Feb. 2023 A | · | 0 | 0 | $0 |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 19 Agu 2026 M | 0 | 0 | 4 | $-3.879.239 |
| Stacy Markel | CHIEF PEOPLE OFFICER | 23 Juni 2026 M | 32.591 | 0 | 1 | $-753.750 |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 23 Juni 2026 M | 53.000 | 0 | 3 | $-1.467.378 |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 17 April 2026 M | 18.000 | 0 | 7 | $-1.866.900 |
| Colleen Sjogren | Chief Commercial Officer | 27 Feb. 2026 A | 81.000 | 0 | 0 | $0 |
| Moses Makunje | Title: VP, Finance and principal financial and accounting officer. | 27 Feb. 2026 A | 68.137 | 0 | 0 | $0 |
| David C. Hanley | CHIEF TECHNICAL OPERATIONS | 27 Feb. 2026 A | 24.000 | 0 | 1 | $-1.428.000 |
| Sergey Yurasov | Chief Medical Officer | 10 Feb. 2021 A | · | 0 | 0 | $0 |
| Thomas Templeman | SVP, Pharmaceutical Ops | 10 Feb. 2021 A | · | 0 | 0 | $0 |
| Robert Mashal | Direktur | 9 Juni 2026 P | 225.000 | 1 | 0 | $118.250 |
| Robert B Bazemore | Direktur | 21 Mei 2026 A | 5.000 | 0 | 0 | $0 |
| Xiangmin Cui | Direktur | 21 Mei 2026 A | 17.062.202 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktur | 21 Mei 2026 A | 250.000 | 0 | 0 | $0 |
| Daniel G Welch | Direktur | 24 Mei 2024 M | 659.947 | 0 | 0 | $0 |
| Oleg Nodelman | Direktur | 29 Okt. 2021 A | · | 0 | 0 | $0 |
| Graham K Cooper | Direktur | 10 Feb. 2021 M | 25.000 | 0 | 0 | $0 |
| Shalini Sharp | Direktur | 10 Feb. 2021 M | 35.000 | 0 | 0 | $0 |
| Faheem Hasnain | Direktur | 10 Feb. 2021 M | 55.000 | 0 | 0 | $0 |
| Daniel Bradbury | Direktur | 10 Feb. 2021 M | 25.000 | 0 | 0 | $0 |
| Anthony W Vernon | · | 21 Mei 2026 A | 304.100 | 0 | 0 | $0 |
| Kim D Blickenstaff | · | 21 Mei 2026 A | 172.189 | 0 | 0 | $0 |
| David Hung | · | 27 Feb. 2026 A | 59.281.054 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 38 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,77% | 275.843 NS | 31 Juli 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,57% | 51.286 NS | 31 Juli 2026 | N-PORT |
| IDNA · iShares Trust | 1,51% | 613.529 SH | 11 Sep. 2026 | Harian |
| PTH · Invesco Exchange-Traded Fund Trust | 1,20% | 732.575 SH | 23 Okt. 2026 | Harian |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 909.498 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,37% | 855.978 SH | 11 Sep. 2026 | Harian |
| IHE · iShares Trust | 0,35% | 902.180 SH | 11 Sep. 2026 | Harian |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,32% | 265.449 SH | 23 Okt. 2026 | Harian |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,21% | 460.740 NS | 31 Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 10.233 NS | 31 Juli 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 237.789 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,12% | 1.891.272 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,10% | 2.370.008 SH | 11 Sep. 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 82.391 NS | 31 Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 270.228 SH | 19 Agu 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 218.055 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,05% | 6.449.970 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,05% | 120.391 NS | 31 Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 201.792 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.450.662 SH | 19 Agu 2026 | Harian |
| TECB · iShares Trust | 0,03% | 24.294 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 163.106 SH | 23 Okt. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 115.286 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.787.165 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,02% | 730.126 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,02% | 430.890 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 13.480 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,01% | 405.885 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.055 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 70.393 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 310.102 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 5.348 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 37.633 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8.849.329 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19.595 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 10.466 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 51.844 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 88.212 SH | 11 Sep. 2026 | Harian |
NUVB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 19 analis
BELI
Target median
$12.00
+162,6%
5 26,3%
Beli Kuat
12 63,2%
Beli
2 10,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
11 analis · 2026-10-23Target rata-rata $13.00 +184,5%
← Di bawah semua target
Harga saat ini $4.57
Rendah$7.00
Rata-rata$13.00
Tinggi$21.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026